Emily Devasagayam

Risk factors associated with the mucormycosis epidemic during the COVID-19 pandemic

Kundakarla Bhanuprasad, Abi Manesh, Emily Devasagayam et al. · International Journal of Infectious Diseases · 2021 · 62 citations · Full text

Effectiveness of Adjunctive High-Dose Infliximab Therapy to Improve Disability-Free Survival Among Patients With Severe Central Nervous System Tuberculosis: A Matched Retrospective Cohort Study

Abi Manesh, Priyanka Gautam, Selwyn Selva Kumar D et al. · Clinical Infectious Diseases · 2023 · 26 citations

Accuracy of Xpert MTB/RIF Ultra for the diagnosis of tuberculosis in adult patients: a retrospective cohort study

Chintan Kaswala, Yvonne Schmiedel, Debasree Kundu et al. · International Journal of Infectious Diseases · 2022 · 23 citations · Full text

Are physicians ready for precision antibiotic prescribing? A qualitative analysis of the acceptance of artificial intelligence-enabled clinical decision support systems in India and Singapore

Zhilian Huang, Mithun Mohan George, Yi-Roe Tan et al. · Journal of Global Antimicrobial Resistance · 2023 · 22 citations · Full text

Short intravenous amphotericin B followed by oral posaconazole using a simple, stratified treatment approach for diabetes or COVID-19-associated rhino-orbito-cerebral mucormycosis: a prospective cohort study

Abi Manesh, Emily Devasagayam, Kundakarla Bhanuprasad et al. · Clinical Microbiology and Infection · 2023 · 13 citations · Full text